EPIDEMIOLOGY OF GASTROESOPHAGEAL REFLUX DISEASE AND REFLUX ESOPHAGITIS: THE SYSTEMATIC INVESTIGATION OF GASTROINTESTINAL DISEASES IN CHINA (SILC)

(1) Changhai Hospital and

(2) Department of Health Statistics, Second Military Medical University, Shanghai, China

(3) AstraZeneca Pharmaceutical Co. Ltd, Shanghai, China

(4) Royal Adelaide Hospital, Adelaide, Australia

(5) Chinese University of Hong Kong, Hong Kong, China

(6) University of Genoa, Genoa, Italy



This item was part of the OESOPHAGEAL, GASTRIC AND DUODENAL DISORDERS II session at Gastro 2009 UEGW/WCOG London (17th UEGW)